Clinical
RSSArticles
-
Sarecycline Tablets (Seysara)
Sarecycline is indicated for the treatment of inflammatory lesions of non-nodular moderate to severe acne in patients 9 years of age and older.
-
Is Sanitizer Better Than Soap?
In day care settings, the implementation of hand hygiene programs reduced respiratory illness, absenteeism, and antibiotic use in children 0-3 years of age. Using hand sanitizer was more effective than washing with soap and water.
-
Trends in Supplemental Vitamin D Intake
Researchers investigated the trends in daily supplemental vitamin D intake of ≥ 1,000 IU and ≥ 4,000 IU and found increasing use of vitamin D supplementation.
-
Scientists Focus on Rapid Chlamydia Test
Just-released research findings indicate that a potential rapid chlamydia test delivers accurate results in about 30 minutes, which could make it possible for patients to be treated right away. Such point-of-care testing could help eliminate the need for follow-up appointments because patients would receive treatment at the time of diagnosis, say researchers.
-
New Report Makes Case to Act Against Skyrocketing STDs
A new review by the National Academy of Public Administration makes a convincing case to act against skyrocketing sexually transmitted disease rates.
-
Consider Vaginal Estrogen for Genitourinary Syndrome of Menopause
-
Gabapentin May Offer Treatment Option for Vulvodynia
-
Are Women Getting Screened for Cervical Cancer?
-
Research Focuses on Risk of Preterm Birth in Subsequent Pregnancy
In new research, investigators analyzed the risk of preterm birth among women with a previous poor pregnancy outcome. The results indicated that women had a higher chance of delivering before 32 weeks if their previous infant was born small for its gestational age. Those with a previous neonatal death were three times as likely to have a preterm birth subsequently, data indicated.
-
Quick Start for Teen Contraception: What’s Your Stance?
Family planning providers should develop ways to provide contraceptives to patients in one visit (known as Quick Start) for all methods, according to the Family Planning National Training Center’s Contraceptive Access Change Package. New research indicates that while most public-sector and private providers consider Quick Start for combined hormonal contraceptives and depot medroxyprogesterone acetate (DMPA) safe for use among adolescents, fewer private providers utilize the technique.